Janux Therapeutics (JANX) Q1 2026 Earnings

26FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.62
-0.54
-0.46
-0.38

Details

Expected EPS
-0.624844
Actual EPS
-0.51
Surprise EPS
0.11
Surprise Percent
+18.38%

Description

Janux Therapeutics (JANX) has reported earnings of -0.51 per share for Q1 2026.

0 Comments

Share your thoughts